Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMS1 pseudogene 22 (BMS1P22) is a **pseudogene** found on chromosome 22. It is a non-protein-coding homolog of the BMS1 gene, which encodes a ribosome biogenesis factor important for rRNA processing and ribosomal assembly. BMS1P22 does not produce a functional protein and is not implicated as a drug target, biomarker, or therapeutic modulator[4][8]. Pseudogenes in general may act as regulatory noncoding RNAs, but there is no specific evidence for BMS1P22 having any biological function or disease relevance[2][4]. Summary of issues: - BMS1P22 is not a druggable target, receptor, enzyme, transporter, or transcription factor. It is a genomic pseudogene. - There is no disease or drug relevance reported. - Any references to BMS1P22 as a therapeutic target or receptor are incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 pseudogene 22 (BMS1P22).